XML 83 R73.htm IDEA: XBRL DOCUMENT v3.22.0.1
Balance Sheet Components - Schedule of Accrued and Other Current Liabilities (Detail) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Accrued Liabilities Current [Abstract]    
Preclinical and clinical trial accruals $ 56,283 $ 44,113
Acquired in-process research and development asset 35,000 0
Payroll and related accruals 20,909 22,800
Contract liabilities to pharmaceutical distributors 3,176 15,137
Accrued co-promotion expenses - current 25,746 11,537
Roxadustat profit share to AstraZeneca 7,895 7,007
Property taxes and other taxes 12,610 5,970
Professional services 6,074 4,869
Other 4,895 6,900
Total accrued and other current liabilities $ 172,588 $ 118,333